Egypt's government has confirmed that the majority of medicines and medical supplies are stocked for over three months, following a comprehensive review of supply chains and company dues, according to a Cabinet statement released on Sunday. The announcement was made during a high-level meeting chaired by Prime Minister Moustafa Madbouly to examine the status of medicine deliveries, ongoing production, and import activities, alongside strategies to maintain market stability. The Egyptian Drug Authority (EDA) detailed its ongoing efforts to secure raw materials and sustain a strategic stockpile of essential medical products. It also highlighted campaigns targeting malpractice in the sector to ensure the consistent availability of high-quality medicines for public use. Ali El-Ghamrawy, Chairman of the EDA, reported significant progress in monitoring therapeutic groups with limited availability. He noted that stock levels for these key groups currently cover over three months, with some supplies extending up to ten months. Strategic therapeutic categories, including critical medicines, have stock coverage ranging from two to fifteen months, reflecting robust healthcare planning. Prime Minister Madbouly underscored the importance of allocating adequate financial resources to maintain a secure and sustainable stockpile of medicines, especially in light of anticipated price increases in the upcoming fiscal year. He also emphasized the need to support the Unified Procurement Authority in securing long-term medical supplies to meet the country's healthcare demands. Attribution: Amwal Al Ghad English Subediting: Y.Yasser
